Electrophysiology Sample Clauses

Electrophysiology. Charge Nurse 1 without assignment during hours of operation Registered Nurse 2:1 Radiological Technologist 1:1
AutoNDA by SimpleDocs
Electrophysiology. Electrophysiological recordings were carried out using the patch clamp technique in the whole cell configuration. Recordings were made in the voltage clamp mode with the voltage of the cell controlled and whole cell currents recorded. Whole cell recording was carried out by forming a gigaseal between the recording electrode and the cell membrane. Data were acquired at 10 kHz with an amplifier (Axopatch 200B with pClamp 8; Axon Instruments, Foster City, CA). Voltage-clamp data were stored on the computer hard disc and analysed off-line (Clampfit 8; Axon Instruments, and Origin 6.1; OriginLab Co., Northampton, MA). Patch pipettes were pulled from borosilicate glass and when filled with pipette solution, had a resistance of between 1.2 and 2.0 MΩ. Typical cell capacitances were between 7 and 25 pF for both STC-1 cells and KRJ-I cells. Access resistances were between 3.0 and 4.0 MΩ and were compensated up to 70%. The holding potential was −80 mV, unless stated otherwise. The I–V relationship was measured by applying voltage pulses to potentials between −100 and +120 mV in 10-mV increments from a holding potential of −80 mV at 0.2 Hz, For calcium currents voltage pulses between −80 and +80mV in 10-mV or 5mV increments were used. To obtain current densities, the current amplitude was normalized to cell membrane capacitance (Cm). From I– V curves the activation threshold was determined as test potential at which the current was 5% of the maximum current. For KRJ-I cells, a voltage ramp between -100mV and +120mV over one second was used in place of the voltage step protocol. For determination of half-maximum activation voltage (V0.5,act) the chord conductance (G) was calculated from the current-voltage curves by dividing the peak current amplitude by its driving force at that respective potential G = I/(V −Vrev), where Vrev is the extrapolated reversal potential, V is the membrane potential, and I is the peak current. The chord conductance was then fitted with a Boltzmann equation: G = Gmax/(1 + e(V0.5,act−Vm)/kact) Where Gmax is the maximum conductance, V0.5,act is the half-maximum activation voltage, Vm is the test potential, and kact is the slope factor of the activation curve. Membrane potential was measured in current clamp mode. Drugs were applied by close local perfusion system that enabled the solution bathing the cell to be changed in less than 1 second.
Electrophysiology. For voltage clamp experiments a cover slip with DRG cell culture was mounted in a chamber on the stage of an inverted microscope. Patch pipettes were pulled from borosilicate glass (Xxxxx XX−150 TF−15) and had resistances of 2.0 to 2.5 M▲ measured in the standard bath solution. Sintered Ag/AgCl electrodes coupled the amplifier input leads to the solutions. To minimize offset caused by low Cl− pipette solutions, the pipette holder (Xxxxxxx et al., 1990) contained a Cl− rich solution at the Ag/AgCl electrode. Giga−seals were made in a microbath of ~75 µl, continuously perfused (~300 µl.min−1) with the standard bath solution (in mM): NaCl 145, KCl 5, CaCl2 2, MgCl2 1, HEPES 10, pH 7.4 (NaOH). The pipette solution contained (mM): Cs− methanesulfonate 103, MgCl2 4, HEPES 9, EGTA 9, (Mg)ATP 4, (tris)GTP 1, (tris)phosphocreatine 14, pH 7.4 (CsOH). After establishment of the whole−cell configuration the barium current was recorded with voltage−step protocols during extracellular perfusion with (mM): TEA−Cl 160, HEPES 10, EGTA 0.1, BaCl2 5, pH 7.4 (TEA−OH). A PC running Clampex 7 (Axon Instruments, Foster City, CA) and a List EPC 7 amplifier provided voltage protocols. Up to 80−90% of the series resistance was compensated. The membrane currents were filtered at 3 kHz in general and at 10 kHz for tail current measurements. Control experiments with an equivalent RC−circuit of the whole−cell showed that current transients with time constants of >100 µs can be reliably measured at 10 kHz filter setting (3−pole Bessel) under our conditions. All currents were leak subtracted using the P/4 method. Membrane capacitance of the selected DRG neurons was 14 ± 3 pF (n = 55). Calcium currents during action− potential clamp were measured under constant perfusion with (mM): TEA−Cl 160, HEPES 10, CaCl2 2, pH 7.4 (TEA−OH). The pipette solution was the same as above in the step voltage−clamp conditions.

Related to Electrophysiology

  • Diagnostic procedures to aid the Provider in determining required dental treatment.

  • OPTICAL ‌ The Employer agrees to provide Optical coverage for active full- time employees in the amount of one hundred twenty-five dollars ($125.00) every twenty-four (24) month period, for the cost of frames, lenses and the fitting of prescription glasses when recommended by a doctor or optometrist. Sunglasses or glasses for cosmetic purposes are not included nor is the cost of eye examinations. While this Appendix is intended to provide an overview of all benefit coverages the insurer’s plan documents will ultimately govern the administration of these benefits. RRSP‌ The Employer agrees to contribute the following amounts to a Registered Retirement Savings Plan for any full-time employee who agrees to contribute an equal amount as follows: Employer Employee Year 1 $550.00 $550.00 Year 2 $550.00 $550.00 Reflect yearly Employer and Employee contribution match. Such amounts shall be divided by the amount of pay periods for each year and shall be adjusted accordingly.

  • Screening 3.13.1 Refuse containers located outside the building shall be fully screened from adjacent properties and from streets by means of opaque fencing or masonry walls with suitable landscaping.

  • Insulin Insulin will be treated as a prescription drug subject to a separate copay for each type prescribed.

  • Diagnosis For a condition to be considered a covered illness or disorder, copies of laboratory tests results, X-rays, or any other report or result of clinical examinations on which the diagnosis was based, are required as part of the positive diagnosis by a physician.

  • Speech Therapy This plan covers speech therapy services when provided by a qualified licensed provider and part of a formal treatment plan for: • loss of speech or communication function; or • impairment as a result of an acute illness or injury, or an acute exacerbation of a chronic disease. Speech therapy services must relate to: • performing basic functional communication; or • assessing or treating swallowing dysfunction. See Autism Services when speech therapy services are rendered as part of the treatment of autism spectrum disorder. The amount you pay and any benefit limit will be the same whether the services are provided for habilitative or rehabilitative purposes.

  • Prosthodontics We Cover prosthodontic services as follows: • Removable complete or partial dentures, for Members 15 years of age and above, including six (6) months follow-up care; • Additional services including insertion of identification slips, repairs, relines and rebases and treatment of cleft palate; and • Interim prosthesis for Members five (5) to 15 years of age. We do not Cover implants or implant related services. Fixed bridges are not Covered unless they are required: • For replacement of a single upper anterior (central/lateral incisor or cuspid) in a patient with an otherwise full complement of natural, functional and/or restored teeth; • For cleft palate stabilization; or • Due to the presence of any neurologic or physiologic condition that would preclude the placement of a removable prosthesis, as demonstrated by medical documentation.

  • Device In this agreement, “device” means a physical hardware system) with an internal storage device capable of running the software. A hardware partition or blade is considered to be a device.

  • Probes Network hosts used to perform (DNS, EPP, etc.) tests (see below) that are located at various global locations.

  • Devices BNY Mellon will restrict the transfer of Customer Data from its network to mass storage devices. BNY Mellon will use a mobile device management system or equivalent tool when mobile computing is used to provide the services. Applications on such authenticated devices will be housed within an encrypted container and BNY Mellon will maintain the ability to remote wipe the contents of the container.

Time is Money Join Law Insider Premium to draft better contracts faster.